Terms: = Bone cancer AND CD79B, ENSG00000007312, 974, P40259, IGB, B29
82 results:
1. Sex- and Age-Specific Prevalence of Osteopenia and Osteoporosis: Sampling Survey.
Fan Y; Li Q; Liu Y; Miao J; Zhao T; Cai J; Liu M; Cao J; Xu H; Wei L; Li M; Shen C
JMIR Public Health Surveill; 2024 Apr; 10():e48947. PubMed ID: 38578689
[TBL] [Abstract] [Full Text] [Related]
2. A machine learning radiomics model based on bpMRI to predict bone metastasis in newly diagnosed prostate cancer patients.
Xinyang S; Shuang Z; Tianci S; Xiangyu H; Yangyang W; Mengying D; Jingran Z; Feng Y
Magn Reson Imaging; 2024 Apr; 107():15-23. PubMed ID: 38181835
[TBL] [Abstract] [Full Text] [Related]
3. Human cd79b
Meyer MA; Dinh HQ; Alimadadi A; Araujo DJ; Chatterjee N; Gutierrez NA; Zhu YP; Hunter EL; Liang S; Seumois G; Kiosses WB; Catz SD; Vijayanand P; Ottensmeier C; Hedrick CC
Front Immunol; 2023; 14():1224045. PubMed ID: 38022639
[TBL] [Abstract] [Full Text] [Related]
4. Sensitivities evaluation of five radiopharmaceuticals in four common medullary thyroid carcinoma metastatic sites on PET/CT: a network meta-analysis and systematic review.
Li P; Zhang Y; Xu T; Zhu J; Wei T; Zhao W
Nucl Med Commun; 2023 Dec; 44(12):1114-1125. PubMed ID: 37769014
[TBL] [Abstract] [Full Text] [Related]
5. Development and Validation of a Convolutional Neural Network Model to Predict a Pathologic Fracture in the Proximal Femur Using Abdomen and Pelvis CT Images of Patients With Advanced cancer.
Joo MW; Ko T; Kim MS; Lee YS; Shin SH; Chung YG; Lee HK
Clin Orthop Relat Res; 2023 Nov; 481(11):2247-2256. PubMed ID: 37615504
[TBL] [Abstract] [Full Text] [Related]
6. Radiomics analysis of bone marrow biopsy locations in [
Milara E; Alonso R; Masseing L; Seiffert AP; Gómez-Grande A; Gómez EJ; Martínez-López J; Sánchez-González P
Phys Eng Sci Med; 2023 Jun; 46(2):903-913. PubMed ID: 37155114
[TBL] [Abstract] [Full Text] [Related]
7. Cost savings and cost avoidance with the inpatient clinical pharmacist interventions in a tertiary cancer care hospital.
Abushanab D; Gulied A; Hamad A; Abu-Tineh M; Abdul Rouf PV; Al Hail M; El-Kassem W; El Hajj MS; Al-Badriyeh D
J Oncol Pharm Pract; 2023 Dec; 29(8):1935-1943. PubMed ID: 36946146
[TBL] [Abstract] [Full Text] [Related]
8. New insights into breast microcalcification for poor prognosis: NACT cohort and bone metastasis evaluation cohort.
Hu Y; Mao L; Wang M; Li Z; Li M; Wang C; Ji L; Zeng H; Zhang X
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7285-7297. PubMed ID: 36917189
[TBL] [Abstract] [Full Text] [Related]
9. Association Between Insurance Status and Chondrosarcoma Stage at Diagnosis in the United States: Implications for Detection and Outcomes.
Yatham P; Garcia J; Fagundo V; Castro G; Rodriguez de la Vega P; Ruiz JG; Belzarena AC
J Am Acad Orthop Surg; 2023 Feb; 31(4):e189-e197. PubMed ID: 36730695
[TBL] [Abstract] [Full Text] [Related]
10. Preoperative Prediction of Sinonasal Inverted Papilloma-associated Squamous Cell Carcinoma (IP-SCC).
Park MJ; Cho W; Kim JH; Chung YS; Jang YJ; Yu MS
Laryngoscope; 2023 Oct; 133(10):2502-2510. PubMed ID: 36683553
[TBL] [Abstract] [Full Text] [Related]
11. Peri-osteosarcoma adipose computed tomography attenuation and volume for predicting chemotherapy response in pediatric patients.
Fu D
Clin Transl Oncol; 2023 Jun; 25(6):1710-1718. PubMed ID: 36640208
[TBL] [Abstract] [Full Text] [Related]
12. Efficacy and safety of carbon ion radiotherapy for bone sarcomas: a systematic review and meta-analysis.
Dong M; Liu R; Zhang Q; Luo H; Wang D; Wang Y; Chen J; Ou Y; Wang X
Radiat Oncol; 2022 Oct; 17(1):172. PubMed ID: 36284346
[TBL] [Abstract] [Full Text] [Related]
13. Machine learning predicts the prognosis of breast cancer patients with initial bone metastases.
Li C; Liu M; Li J; Wang W; Feng C; Cai Y; Wu F; Zhao X; Du C; Zhang Y; Wang Y; Zhang S; Qu J
Front Public Health; 2022; 10():1003976. PubMed ID: 36225783
[TBL] [Abstract] [Full Text] [Related]
14. A multicenter retrospective study of polatuzumab vedotin in patients with large B-cell lymphoma after CAR T-cell therapy.
Gouni S; Rosenthal AC; Crombie JL; Ip A; Kamdar MK; Hess B; Feng L; Watson G; Ayers A; Neelapu SS; Khurana A; Lin Y; Iqbal M; Merryman RW; Strati P
Blood Adv; 2022 May; 6(9):2757-2762. PubMed ID: 35240681
[TBL] [Abstract] [Full Text] [Related]
15. bone Suppression on Chest Radiographs for Pulmonary Nodule Detection: Comparison between a Generative Adversarial Network and Dual-Energy Subtraction.
Bae K; Oh DY; Yun ID; Jeon KN
Korean J Radiol; 2022 Jan; 23(1):139-149. PubMed ID: 34983100
[TBL] [Abstract] [Full Text] [Related]
16. EIF3B Associates with Exacerbated Clinical Features, Poor Treatment Response and Survival in Adult Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia Patients.
Zhu F; Fu Y; He X
Technol Cancer Res Treat; 2021; 20():15330338211041464. PubMed ID: 34617851
[No Abstract] [Full Text] [Related]
17. Role of PSA Kinetics in Hormone-refractory Prostate cancer.
Sabur V; Untan I; Tatlisen A
J Coll Physicians Surg Pak; 2021 Jun; 31(6):673-678. PubMed ID: 34102779
[TBL] [Abstract] [Full Text] [Related]
18. Post-progression outcomes of NSCLC patients with PD-L1 expression ≥ 50% receiving first-line single-agent pembrolizumab in a large multicentre real-world study.
Cortellini A; Cannita K; Tiseo M; Cortinovis DL; Aerts JGJV; Baldessari C; Giusti R; Ferrara MG; D'Argento E; Grossi F; Guida A; Berardi R; Morabito A; Genova C; Antonuzzo L; Mazzoni F; De Toma A; Signorelli D; Gelibter A; Targato G; Rastelli F; Chiari R; Rocco D; Gori S; De Tursi M; Mansueto G; Zoratto F; Filetti M; Bracarda S; Citarella F; Russano M; Cantini L; Nigro O; Buti S; Minuti G; Landi L; Ricciardi S; Migliorino MR; Natalizio S; Simona C; De Filippis M; Metro G; Adamo V; Russo A; Spinelli GP; Di Maio M; Banna GL; Friedlaender A; Addeo A; Pinato DJ; Ficorella C; Porzio G
Eur J Cancer; 2021 May; 148():24-35. PubMed ID: 33721704
[TBL] [Abstract] [Full Text] [Related]
19. Radiation exposure during the treatment of spinal deformities.
Mehta JS; Hodgson K; Yiping L; Kho JSB; Thimmaiah R; Topiwala U; Sawlani V; Botchu R
Bone Joint J; 2021 Apr; 103-B(4):1-7. PubMed ID: 33595351
[TBL] [Abstract] [Full Text] [Related]
20. Real-life experience with the combination of polatuzumab vedotin, rituximab, and bendamustine in aggressive B-cell lymphomas.
Dimou M; Papageorgiou SG; Stavroyianni N; Katodritou E; Tsirogianni M; Kalpadakis C; Banti A; Arapaki M; Iliakis T; Bouzani M; Verrou E; Spanoudakis E; Giannouli S; Marinakis T; Mandala E; Mparmparousi D; Sachanas S; Dalekou-Tsolakou M; Hatzimichael E; Vadikolia C; Violaki V; Poziopoulos C; Tsirkinidis P; Chatzileontiadou S; Vervessou E; Ximeri M; Sioni A; Konstantinidou P; Kyrtsonis MC; Siakantaris MP; Angelopoulou MK; Pappa V; Konstantopoulos K; Panayiotidis P; Vassilakopoulos TP
Hematol Oncol; 2021 Aug; 39(3):336-348. PubMed ID: 33583077
[TBL] [Abstract] [Full Text] [Related]
[Next]
